Literature DB >> 25088301

Making proteins in the powerhouse.

B Martin Hällberg1, Nils-Göran Larsson2.   

Abstract

Understanding regulation of mitochondrial DNA (mtDNA) expression is of considerable interest given that mitochondrial dysfunction is important in human pathology and aging. Similar to the situation in bacteria, there is no compartmentalization between transcription and translation in mitochondria; hence, both processes are likely to have a direct molecular crosstalk. Accumulating evidence suggests that there are important mechanisms for regulation of mammalian mtDNA expression at the posttranscriptional level. Regulation of mRNA maturation, mRNA stability, translational coordination, ribosomal biogenesis, and translation itself all form the basis for controlling oxidative phosphorylation capacity. Consequently, a wide variety of inherited human mitochondrial diseases are caused by mutations of nuclear genes regulating various aspects of mitochondrial translation. Furthermore, mutations of mtDNA, associated with human disease and aging, often affect tRNA genes critical for mitochondrial translation. Recent advances in molecular understanding of mitochondrial translation regulation will most likely provide novel avenues for modulating mitochondrial function for treating human disease.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25088301     DOI: 10.1016/j.cmet.2014.07.001

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  88 in total

Review 1.  Integrating mitochondrial translation into the cellular context.

Authors:  Ricarda Richter-Dennerlein; Sven Dennerlein; Peter Rehling
Journal:  Nat Rev Mol Cell Biol       Date:  2015-10       Impact factor: 94.444

2.  A little less leads to lots more.

Authors:  Jonathan R Warner
Journal:  Nat Struct Mol Biol       Date:  2015-05       Impact factor: 15.369

Review 3.  Beyond the unwinding: role of TOP1MT in mitochondrial translation.

Authors:  Simone A Baechler; Ilaria Dalla Rosa; Antonella Spinazzola; Yves Pommier
Journal:  Cell Cycle       Date:  2019-08-09       Impact factor: 4.534

Review 4.  Mitochondrial fidelity and metabolic agility control immune cell fate and function.

Authors:  Michael N Sack
Journal:  J Clin Invest       Date:  2018-07-30       Impact factor: 14.808

5.  Mitochondrial biology. Replication-transcription switch in human mitochondria.

Authors:  Karen Agaronyan; Yaroslav I Morozov; Michael Anikin; Dmitry Temiakov
Journal:  Science       Date:  2015-01-30       Impact factor: 47.728

6.  PTCD1 Is Required for Mitochondrial Oxidative-Phosphorylation: Possible Genetic Association with Alzheimer's Disease.

Authors:  Daniel Fleck; Lilian Phu; Erik Verschueren; Trent Hinkle; Mike Reichelt; Tushar Bhangale; Benjamin Haley; Yuanyuan Wang; Robert Graham; Donald S Kirkpatrick; Morgan Sheng; Baris Bingol
Journal:  J Neurosci       Date:  2019-04-04       Impact factor: 6.167

Review 7.  Mitochondrial Morphofunction in Mammalian Cells.

Authors:  Elianne P Bulthuis; Merel J W Adjobo-Hermans; Peter H G M Willems; Werner J H Koopman
Journal:  Antioxid Redox Signal       Date:  2018-11-29       Impact factor: 8.401

Review 8.  Mitochondrial function in hypoxic ischemic injury and influence of aging.

Authors:  P Benson Ham; Raghavan Raju
Journal:  Prog Neurobiol       Date:  2016-06-16       Impact factor: 11.685

Review 9.  When a common biological role does not imply common disease outcomes: Disparate pathology linked to human mitochondrial aminoacyl-tRNA synthetases.

Authors:  Ligia Elena González-Serrano; Joseph W Chihade; Marie Sissler
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

10.  Mitochondrial ribosomal protein PTCD3 mutations cause oxidative phosphorylation defects with Leigh syndrome.

Authors:  Nurun Nahar Borna; Yoshihito Kishita; Masakazu Kohda; Sze Chern Lim; Masaru Shimura; Yibo Wu; Kaoru Mogushi; Yukiko Yatsuka; Hiroko Harashima; Yuichiro Hisatomi; Takuya Fushimi; Keiko Ichimoto; Kei Murayama; Akira Ohtake; Yasushi Okazaki
Journal:  Neurogenetics       Date:  2019-01-03       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.